<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - INSULINS</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drugClass/">Drug classes</a></li>
      </ul>

      <h1>INSULINS</h1>

      <nav>
        <ul class="nav nav-list">

          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#monitoringRequirements" data-toggle="tab">Monitoring requirements</a></li>
          <li><a href="#prescribingAndDispensingInformation" data-toggle="tab">Prescribing and dispensing</a></li>
          <li><a href="#drugsInClass" data-toggle="tab">Drugs in class</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="doseAdjustments">
              <p>Insulin requirements may be decreased in patients with hepatic impairment.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

            <section class="doseAdjustments">
              <p>Insulin requirements may decrease in patients with renal impairment and therefore dose reduction may be necessary.</p>
            </section>
        
            <section class="generalInformation">
              <p> The compensatory response to hypoglycaemia is impaired in renal impairment.</p>
            </section>
      </section>


      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> Fat hypertrophy at injection site, local reactions at injection site, transient oedema,
              </p>
              <p>
                <strong>rare:</strong> Hypersensitivity reactions, rash, urticaria,
              </p>
        
        
        
            <section class="overdosageInformation">
              <p>Overdose causes hypoglycaemia.</p>
            </section>
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <p>Insulin is generally given by <i>subcutaneous injection</i>; the injection site should be rotated to prevent lipodystrophy. Injection devices (&#8216;pens&#8217;), which hold the insulin in a cartridge and meter the required dose, are convenient to use. Insulin syringes (for use with needles) are required for insulins not available in cartridge form, but are less popular with children and carers.</p><p>For intensive insulin regimens multiple subcutaneous injections (3 or more times daily) are usually recommended.</p>
            </section>
      </section>

      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="generalPatientAdvice">
                <h3>Hypoglycaemia</h3>
              <p>Hypoglycaemia is a potential problem with insulin therapy. All patients must be carefully instructed on how to avoid it; this involves appropriate adjustment of insulin type, dose and frequency together with suitable timing and quantity of meals and snacks.</p>
            </section>
            <section class="patientResources">
                <h3>Insulin Passport</h3>
              <p>Insulin Passports and patient information booklets should be offered to patients receiving insulin. The Insulin Passport provides a record of the patient&#8217;s current insulin preparations and contains a section for emergency information. The patient information booklet provides advice on the safe use of insulin. They are available for purchase from:</p><ul outputclass="organization">
            <li outputclass="organizationname">3M Security Print and Systems Limited</li>
            <li outputclass="thoroughfare">Gorse Street, Chadderton</li>
            <li outputclass="localityname">Oldham</li>
            <li outputclass="postalcode">OL9 9QH</li>
            <li outputclass="contactnumber">0845 610 1112</li>
            </ul><p>GP practices can obtain supplies through their Local Area Team stores.</p><p>NHS Trusts can order supplies from <xref format="html" href="https://www.nhsforms.co.uk">www.nhsforms.co.uk</xref> or by emailing nhsforms@mmm.com. Further information is available at <xref format="html" href="http://www.npsa.nhs.uk">www.npsa.nhs.uk</xref>.</p>
            </section>
      </section>





      <section class="tab-pane" id="monitoringRequirements">
        <h2>Monitoring requirements</h2>

        
          <h3>Patient parameters</h3>
        
            <section class="patientParameters">
              <p>Many patients now monitor their own blood-glucose concentrations; all carers and children need to be trained to do this.</p><p>Since blood-glucose concentration varies substantially throughout the day, &#8216;normoglycaemia&#8217; cannot always be achieved throughout a 24-hour period without causing damaging hypoglycaemia.</p>
            </section>
            <section class="patientParameters">
              <p>It is therefore best to recommend that patients should maintain a blood-glucose concentration of between 4 and 9&#8239;mmol/litre for most of the time (4&#8211;7&#8239;mmol/litre before meals and less than 9&#8239;mmol/litre after meals).</p>
            </section>
            <section class="patientParameters">
              <p>While accepting that on occasions, for brief periods, the blood-glucose concentration will be above these values; strenuous efforts should be made to prevent it from falling below 4&#8239;mmol/litre. Patients using multiple injection regimens should understand how to adjust their insulin dose according to their carbohydrate intake. With fixed-dose insulin regimens, the carbohydrate intake needs to be regulated, and should be distributed throughout the day to match the insulin regimen. The intake of energy and of simple and complex carbohydrates should be adequate to allow normal growth and development but obesity must be avoided.</p>
            </section>
      </section>


      <section class="tab-pane" id="prescribingAndDispensingInformation">
        <h2>Information regarding prescribing and dispensing</h2>

            <section class="prescribingAndDispensingInformation">
                <h3>Units</h3>
              <p>The word 'unit' should <b>not</b> be abbreviated.</p>
            </section>
            <section class="prescribingAndDispensingInformation">
              <p>Show container to patient or carer and confirm the expected version is dispensed.</p>
            </section>
      </section>









      <section class="tab-pane" id="drugsInClass">
        <h2>Drugs in the class of INSULINS</h2>

          <ul>
            <li><a href="../drug/PHP33119.html">INSULIN DEGLUDEC</a></li>
            <li><a href="../drug/PHP4049.html">INSULIN</a></li>
            <li><a href="../drug/PHP4060.html">INSULIN ASPART</a></li>
            <li><a href="../drug/PHP4062.html">INSULIN GLULISINE</a></li>
            <li><a href="../drug/PHP4064.html">INSULIN LISPRO</a></li>
            <li><a href="../drug/PHP4070.html">INSULIN DETEMIR</a></li>
            <li><a href="../drug/PHP4072.html">INSULIN GLARGINE</a></li>
            <li><a href="../drug/PHP4076.html">INSULIN ZINC SUSPENSION</a></li>
            <li><a href="../drug/PHP4079.html">ISOPHANE INSULIN</a></li>
            <li><a href="../drug/PHP4088.html">PROTAMINE ZINC INSULIN</a></li>
            <li><a href="../drug/PHP4091.html">BIPHASIC INSULIN ASPART</a></li>
            <li><a href="../drug/PHP4093.html">BIPHASIC INSULIN LISPRO</a></li>
            <li><a href="../drug/PHP4096.html">BIPHASIC ISOPHANE INSULIN</a></li>
          </ul>
      </section>

    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
</body>
</html>
